Fonar Logo
diagnostic imaging management services

* FONAR is not responsible for the accuracy of information on these servers. This link is provided for your convenience only.

 

Fonar Financials Filed with the SEC

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

 

SEC Accession No. 0000355019-23-000007

Filing Date
2023-02-14
Accepted
2023-02-14 16:16:03
Documents
60
Period of Report
2022-12-31
 
Interactive Data
Document Format Files
Seq Description Document Type
1   fonar_10-q.htm iXBRL 10-Q
2 SECTION 302 CERTIFICATION fonar_exhibit-31.htm EX-31.1
3 SECTION 906 CERTIFICATION fonar_exhibit-32.htm EX-32.1
9 GRAPHIC fonar-logo.jpg GRAPHIC
  Complete submission text file 0000355019-23-000007.txt  

Data Files
Seq Description Document Type
4 XBRL SCHEMA FILE fonr-20221231.xsd EX-101.SCH
5 XBRL CALCULATION fonr-20221231_cal.xml EX-101.CAL
6 XBRL DEFINITION FILE fonr-20221231_def.xml EX-101.DEF
7 XBRL LABEL FILE fonr-20221231_lab.xml EX-101.LAB
8 XBRL PRESENTATION FILE fonr-20221231_pre.xml EX-101.PRE
53 EXTRACTED XBRL INSTANCE DOCUMENT fonar_10-q_htm.xml XML
       

FONAR CORPORATION (Filer) CIK: 0000355019

IRS No.: 112464137 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-10248 | Film No.: 23629535
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences

Business Address

110 Marcus Drive
Melville, NY 11740
631-694-2929
Mailing Address

110 Marcus Drive
Melville, NY 11740